Search - tctmd.com

Displaying 681 - 700 of 1337

Sort: Relevancy | Date

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico

March 20, 2014

News Daily News

Comunicado de SCAI/ACC/AHA: Las PCI Sin Soporte Quirúrgico son Seguras si se Realizan según Protocolo

Yael L. Maxwell

March 20, 2014

News Daily News

Readmissions Higher with PCI vs CABG for Left Main Disease

March 14, 2014

News Daily News

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

March 14, 2014

Presentation

Readmission Rate after CABG vs PCI for Unprotected Left Main Disease

Presenter: J.H. Roh

March 13, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation CTO 2014

A Thoughtful Surgeon's Approach to Left Main PCI vs CABG Clinical Decision Making

Presenter: Joseph F. Sabik

March 01, 2014

Presentation CTO 2014

So Many Risk Models, So Little Time: A Practical Guide to Choosing between CABG and PCI for Left Main Revascularization

Presenter: Patrick W. Serruys

March 01, 2014

News Daily News

Resultados a Largo Plazo Similares para CABG y SLF en Mujeres con Enfermedad de Tronco Coronario Izdo

February 26, 2014

News Daily News

Long-Term Outcomes Similar for CABG vs DES in Women with Left Main Disease

February 26, 2014

Presentation

PCI with DES vs CABG in Women with Severe Narrowing of the Left Main Coronary Artery

Presenter: G.L. Buchanan

February 23, 2014

News Daily News

Over the Long Haul, TAVR Appears Better Than Surgery for Women

Caitlin E. Cox

February 19, 2014

News Daily News

A la Larga, la TAVR parece Mejor que la Cirugía en Mujeres

Caitlin E. Cox

February 19, 2014

News Daily News

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

Yael L. Maxwell

February 13, 2014

News Daily News

La Terapia Celular No Mejora los Resultados CABG

Jason Kahn

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Cell Therapy Fails to Improve on CABG Results

Jason Kahn

February 13, 2014

Advertisement

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico

Comunicado de SCAI/ACC/AHA: Las PCI Sin Soporte Quirúrgico son Seguras si se Realizan según Protocolo

Readmissions Higher with PCI vs CABG for Left Main Disease

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

Readmission Rate after CABG vs PCI for Unprotected Left Main Disease

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

A Thoughtful Surgeon's Approach to Left Main PCI vs CABG Clinical Decision Making

So Many Risk Models, So Little Time: A Practical Guide to Choosing between CABG and PCI for Left Main Revascularization

Resultados a Largo Plazo Similares para CABG y SLF en Mujeres con Enfermedad de Tronco Coronario Izdo

Long-Term Outcomes Similar for CABG vs DES in Women with Left Main Disease

PCI with DES vs CABG in Women with Severe Narrowing of the Left Main Coronary Artery

Over the Long Haul, TAVR Appears Better Than Surgery for Women

A la Larga, la TAVR parece Mejor que la Cirugía en Mujeres

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

La Terapia Celular No Mejora los Resultados CABG

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Cell Therapy Fails to Improve on CABG Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content